Bright Minds Biosciences Inc C.DRUG

Alternate Symbol(s): DRUG

Healthcare Biotechnology

Bright Minds Biosciences Inc. is a biotechnology company. The Company is focused on developing transformative treatments for neuropsychiatric disorders, epilepsy, and pain. It has a portfolio of next generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as treatment resistant epilepsy, treatment resistant depression, post-traumatic stress disorder (PTSD), and pain. Its pipeline includes BMB-101, BMB-202, and BMB-xxx. BMB-101 is for the treatment of Dravet syndrome and other neurological and neuro-psychiatric disorders. The Company has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling while avoiding off-target effects.

CSE:DRUG - Post by User

Bright Minds Biosciences Inc > 3 Hot Biotech Stocks to Watch $DRUG $NRX $BIOV

<< Previous

Bullboard Posts

Next >>

Comment by Investor10Xon Oct 21, 2024 1:13pm

97 Views

Post# 36275059

RE:3 Hot Biotech Stocks to Watch $DRUG $NRX $BIOV

I would be inclined to add PharmAla biotech (Symbol: MDMA or MDXXf) to that list. The company has signed multiple contracts with high profile hospitals and universities (John Hopkins, Harvard, Mount Sinai, University of Texas) to supply MDMA assisted clinical trials in the US. They are the only company suppling the drug and its a USFDA approved version of the drug.

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand